Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on November 9, 2020. The filing serves to announce the Company's financial results for the period ended September 30, 2020, and provides an update on recent corporate events. The report includes a press release and a letter to stockholders as Exhibits 99.1 and 99.2.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached Exhibits 99.1 and 99.2, which are not included in the source text.
Material Changes
The filing indicates that material information regarding the period ended September 30, 2020, is contained within the furnished exhibits. No specific comparative data or material changes are quantified in the body of this Form 8-K.
Guidance, Outlook, and Risks
The Company issued a press release and a letter to stockholders containing an update on recent corporate events. The filing explicitly states that the information furnished under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless specifically stated. The Company does not assume an obligation to update the information in the future.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue and earnings figures for the period ended September 30, 2020.
- Review Exhibit 99.2 (Letter to Stockholders) for details on recent corporate events and management commentary.
- Verify the status of the Company's liquidity and debt obligations as detailed in the attached exhibits.
- Confirm whether the "update on recent corporate events" includes any material changes to the business model or strategic direction.